Article info
Therapeutics
In patients with coronary artery disease and heart failure, the addition of coronary-artery bypass grafting to medical therapy has no effect on the overall risk of death from any cause, but assessment of suitability for surgery may predict survival benefit in subgroups
- Correspondence to: Terrence M Yau
4N-470, Toronto General Hospital, 200 Elizabeth Street, ON M5G 2C4, Canada. terry.yau{at}uhn.on.ca
Citation
In patients with coronary artery disease and heart failure, the addition of coronary-artery bypass grafting to medical therapy has no effect on the overall risk of death from any cause, but assessment of suitability for surgery may predict survival benefit in subgroups
Publication history
- First published June 26, 2012.
Online issue publication
November 28, 2012
Article Versions
- Previous version (26 June 2012).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions